Literature DB >> 25166874

Next-generation companion diagnostics: promises, challenges, and solutions.

Joseph D Khoury1, Daniel V T Catenacci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25166874      PMCID： PMC4991626          DOI： 10.5858/arpa.2014-0063-ED

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  4 in total

1.  Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.

Authors:  Jean-Yves Douillard; Kelly S Oliner; Salvatore Siena; Josep Tabernero; Ronald Burkes; Mario Barugel; Yves Humblet; Gyorgy Bodoky; David Cunningham; Jacek Jassem; Fernando Rivera; Ilona Kocákova; Paul Ruff; Maria Błasińska-Morawiec; Martin Šmakal; Jean Luc Canon; Mark Rother; Richard Williams; Alan Rong; Jeffrey Wiezorek; Roger Sidhu; Scott D Patterson
Journal:  N Engl J Med       Date:  2013-09-12       Impact factor: 91.245

2.  First FDA authorization for next-generation sequencer.

Authors:  Francis S Collins; Margaret A Hamburg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

3.  A cancer trial scandal and its regulatory backlash.

Authors:  Razelle Kurzrock; Hagop Kantarjian; David J Stewart
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

4.  Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.

Authors:  David R Parkinson; Bruce E Johnson; George W Sledge
Journal:  Clin Cancer Res       Date:  2012-02-01       Impact factor: 12.531
  4 in total
  12 in total

Review 1.  Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial.

Authors:  Joseph D Khoury; Wei-Lien Wang; Victor G Prieto; L Jeffrey Medeiros; Neda Kalhor; Meera Hameed; Russell Broaddus; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2017-08-24       Impact factor: 12.531

Review 2.  Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer.

Authors:  Hanadi El Achi; Joseph D Khoury; Sanam Loghavi
Journal:  Curr Hematol Malig Rep       Date:  2019-10       Impact factor: 3.952

Review 3.  Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria.

Authors:  Maria Sanz-De Pedro; Wei Wang; Rashmi Kanagal-Shamanna; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

4.  Expansion platform type II: testing a treatment strategy.

Authors:  Daniel V T Catenacci
Journal:  Lancet Oncol       Date:  2015-09-03       Impact factor: 41.316

5.  Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.

Authors:  Daniel V T Catenacci; Wei-Li Liao; Lei Zhao; Emma Whitcomb; Les Henderson; Emily O'Day; Peng Xu; Sheeno Thyparambil; David Krizman; Kathleen Bengali; Jamar Uzzell; Marlene Darfler; Fabiola Cecchi; Adele Blackler; Yung-Jue Bang; John Hart; Shu-Yuan Xiao; Sang Mee Lee; Jon Burrows; Todd Hembrough
Journal:  Gastric Cancer       Date:  2015-11-18       Impact factor: 7.370

Review 6.  Companion diagnostics for the targeted therapy of gastric cancer.

Authors:  Changhoon Yoo; Young Soo Park
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 7.  Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity.

Authors:  Daniel V T Catenacci
Journal:  Mol Oncol       Date:  2014-10-18       Impact factor: 6.603

8.  Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.

Authors:  Daniel V T Catenacci; Wei-Li Liao; Sheeno Thyparambil; Les Henderson; Peng Xu; Lei Zhao; Brittany Rambo; John Hart; Shu-Yuan Xiao; Kathleen Bengali; Jamar Uzzell; Marlene Darfler; David B Krizman; Fabiola Cecchi; Donald P Bottaro; Theodore Karrison; Timothy D Veenstra; Todd Hembrough; Jon Burrows
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

9.  Tumor genome analysis includes germline genome: are we ready for surprises?

Authors:  Daniel V T Catenacci; Andrea L Amico; Sarah M Nielsen; Daniel M Geynisman; Brittany Rambo; George B Carey; Cassandra Gulden; Jim Fackenthal; Robert D Marsh; Hedy L Kindler; Olufunmilayo I Olopade
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

10.  Metabolomics goes to work for you.

Authors:  Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2014-09       Impact factor: 2.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.